Active Ingredient: PYRIDOSTIGMINE BROMIDE
Proprietary Name: PYRIDOSTIGMINE BROMIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 105MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N217604
Product Number: 001
Approval Date: Oct 4, 2024
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
